Biopsy specimen by core needle biopsy from the left breast lump showed an invasive ductal carcinoma that was both estrogen receptor (ER)- and progesterone receptor (PgR)-negative with a HER2 of 3+ by immunohistochemistry assay. This evidence concerns the gene PGR and invasive ductal breast carcinoma.